FGF21 and cardiovascular disorder: Because FGF-21 is an adipokine with glucose-lowering effects [8], [13], [28]–[30], it was speculated that the paradoxical increase of this protein in populations with risk of cardiovascular disease is a compensatory mechanism to counteract metabolic stress.